drugset / Trial / NCT00967291
Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy, such as mitomycin C and ifosfamide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving mitomycin C together with ifosfamide works in treating patients with metastatic pancreatic cancer.
Timeline
- Start
- 2006-03
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ifosfamide | Small molecule | 2500 mg/m2 | Intravenous |
| Subject | Mitomycin C | Other / unclassified | 8 mg/m2 | Intravenous |